Editorial: Model-informed drug development and precision dosing in clinical pharmacology practice

被引：4

作者：

Hu, Ke ^{[1
,2
]}

Fu, Meng ^{[3
]}

Huang, Xueting ^{[1
,2
]}

He, Sumei ^{[4
]}

Jiao, Zheng ^{[5
]}

Wang, Dongdong ^{[1
,2
]}

机构：

[1] Xuzhou Med Univ, Sch Pharm, Xuzhou, Jiangsu, Peoples R China

[2] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, Xuzhou, Jiangsu, Peoples R China

[3] Jiangsu Hengrui Pharmaceut Co Ltd, Dept Clin Pharmacol, Shanghai, Peoples R China

[4] Nanjing Univ, Suzhou Hosp, Affiliated Hosp, Dept Pharm,Med Sch, Suzhou, Jiangsu, Peoples R China

[5] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Pharm, Sch Med, Shanghai, Peoples R China

来源：

FRONTIERS IN PHARMACOLOGY | 2023年 / 14卷

基金：

中国国家自然科学基金;

关键词：

model-informed drug development; model-informed precision dosing; clinical pharmacology; modeling and simulation; practice;

D O I：

10.3389/fphar.2023.1224980

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：3

共 11 条

[1] Model Informed Development of SIM0295 in Patients with Gout and Hyperuricemia and Healthy Volunteers Using a Population Pharmacokinetics/ Pharmacodynamics Approach [J].

Chen, Yueting ;

Yang, Yang ;

Xu, Shansen ;

Wang, Chenyu ;

Shu, Pan ;

Zhang, Xiaoyu ;

Huang, Qin ;

Kim, Jin Sook ;

Jiao, Zheng .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (05) :441-450

[2] More Than Pharmacokinetics: Transporters in Clinical Pharmacology [J].

Giacomini, Kathleen M. ;

Huang, Shiew Mei .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (03) :423-426

[3]

[焦正 Jiao Zheng], 2021, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V26, P1215

[4]

[李健 Li Jian], 2020, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V25, P1

[5] Handling Delayed or Missed Dose of Antiseizure Medications A Model-Informed Individual Remedial Dosing [J].

Li, Zi-ran ;

Wang, Chen-yu ;

Lin, Wei-wei ;

Chen, Yue-ting ;

Liu, Xiao-qin ;

Jiao, Zheng .

NEUROLOGY, 2023, 100 (09) :E921-E931

[6] How to handle the delayed or missed dose of rivaroxaban in patients with non-valvular atrial fibrillation: model-informed remedial dosing [J].

Liu, Xiao-Qin ;

Yin, Yi-Wei ;

Wang, Chen-Yu ;

Li, Zi-Ran ;

Zhu, Xiao ;

Jiao, Zheng .

EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (09) :1153-1163

[7] Applications of Model Informed Drug Development (MIDD) in Drug Development Lifecycle and Regulatory Review [J].

Mitra, Amitava ;

Wang, Yaning .

PHARMACEUTICAL RESEARCH, 2022, 39 (08) :1663-1667

[8]

van der Graaf Piet H, 2022, Clin Pharmacol Ther, V112, P191, DOI 10.1002/cpt.2680

[9] Population pharmacokinetics of the anti-PD-1 antibody camrelizumab in patients with multiple tumor types and model-informed dosing strategy [J].

Wang, Chen-yu ;

Sheng, Chang-cheng ;

Ma, Guang-li ;

Xu, Da ;

Liu, Xiao-qin ;

Wang, Yu-ya ;

Zhang, Li ;

Cui, Chuan-liang ;

Xu, Bing-he ;

Song, Yu-qin ;

Zhu, Jun ;

Jiao, Zheng .

ACTA PHARMACOLOGICA SINICA, 2021, 42 (08) :1368-1375

[10] Bring the life stages into the domain of basic and clinical pharmacology [J].

Yao, Lan ;

Graff, J. Carolyn ;

Aleya, Lotfi ;

Jiao, Yan ;

Gu, Weikuan ;

Tian, Geng .

FRONTIERS IN PHARMACOLOGY, 2022, 13

← 1 2 →